维普期刊资源整合服务平台（V6.5）

41篇 您的检索式：作者名="Shord"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Randomized doubleblind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy显示文摘	Imad Treish Stacy Shord John Valgus	2003	Support Care Cancer2003，8，：	1
2	Gemcitabine pharmacokinetics and interaction with advanced non - small -cell lung cancer显示文摘	Shord SS Faucette SR Gillenwateer HH	2003	Cancer Chemother Pharmacol2003，51，4：	1
3	Regulation of eytoehrome P450 2C9 expression in primary cultures of human hepatoeytes显示文摘	Sahi J Shord S S Lindley C	2009	J Biochem Mol Toxicol2009，23，1：	1
4	Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines显示文摘	Shord SS Patel SR	2009	J Exp Clin Cancer Res2009，28，3：	1
5	Gemc itabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer 显示文摘	Faucette SR Gillenwater HH	2003	Cancer Chemother Pharmacol2003，51，4：	1
6	Gemcitabinepharmacokinetics and interaction with paclitaxel in patients withadvanced non- small- cell lung cancer显示文摘	Fancette SR Gillenwater HH	2003	Cancer ChemotherPharmacol2003，51，：	1
7	Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small cell lung cancer 显示文摘	Shord S S Faucette S R Gillenwater H H	2003	Cancer Chemother Pharmacol2003，51，4：	1
8	Oxaliplatin biotransformation and pharmacokinetics:a pilot study to determine the possible relationship to neurotoxicity显示文摘	Shord SS Bernard SA Lindley C	2002	Anticancer Res2002，22，4：	1
9	Prepation and properties of acid-solubilized bluten conformation 显示文摘	Woodar J C Shord D D J	1973	Nutrition1973，，：	1
10	Single-dose rasburicase for tumour lysis syndrome in adults:weight-based approach显示文摘	Campara M Shord SS Haaf CM	2009	J Clin Pharm Ther2009，34，2：	1
11	Epigenetics and oncology显示文摘	Mummaneni P Shord SS	2014	Pharmacotherapy2014，34，5：	1
12	Gemcitabine pharmacekinetics and interaction with paclitaxel in patients with advanced non-small cell lung cancer显示文摘	Shord SS Faucette SR GiUenwater HH	2003	Cancer Chemother Pharmacol2003，51，4：	1
13	Understanding and managing the possible adverse effects associated with bevacizumab显示文摘	STACY S. SHORD LINDA R. BRESSLER LAURYN A. TIERNEY SANDRA CUELLAR AMINA GEORGE	2009	American Journal of Health-System Pharmacy2009，，11：	1
14	Gemcitabine pharmacoki- netics and interaction with paclitaxel in patients with advanced non-smaU cell lung cancer 显示文摘	Shord SS Fancette SR Gillenwater HH	2003	Cancer Chemother Pharmacol2003，51，4：	1
15	Randomized double - blind study of the Reliefland as an adjunct to standard antiemetics in patients receiving moderately - high tohighly emetogenic chemo- therapy 显示文摘	Imad Treish Stacy Shord John Valgus	2003	Support Care Cancer2003，11，：	1
16	Oxaliplatin biotransformation and pharmacokinetics:a pilot study to determine the possible relationship to neurotoxicity显示文摘	Shord SS Bernard SA Lindley C	2002	Anticancer Res2002，22，4：	1
17	Optical flow techniques for moving target detection显示文摘	Russo P Marandey V Bui T Shorde D	1990	SPIE Proceedings1990，1383，：	1
18	Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer显示文摘	SHORD S S FAUCETTE S R GILLENWATER H H	2003	Cancer Chemother Pharmacol2003，51，4：	1
19	Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer显示文摘	SHORD S S FAUCETTE S R GILLENWATER H H	2003	Cacer Chemother Pharmacol2003，51，4：	1
20	Cemcitabine phanna-cokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer显示文摘	Shord SS Faucette SR Gillenwater HH	2003	Cancer Chemother Pharmacol2003，51，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示